Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rankning i aktier #6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Aktiekurs
$14.30
Senast synkroniserad: 2023-06-29
Marknadsvärde
$1.81B
Förändring (1 dag)
-2.81%
Förändring (1 år)
0.00%
Land
CA
Handel BELLUS Health Inc. (BLU)

Kategori

Historik för aktiesplit för BELLUS Health Inc. (BLU)
Aktien BELLUS Health Inc. (symbol: BLU) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 28, 2026.
En BLU-aktie köpt före Aug 28, 2026 motsvarar nu 0 BLU-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH